慢性阻塞性肺疾病及哮喘重叠综合征患者临床特征及其区别剖析.docVIP

慢性阻塞性肺疾病及哮喘重叠综合征患者临床特征及其区别剖析.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
慢性阻塞性肺疾病及哮喘重叠综合征患者临床特征及其区别剖析

慢性阻塞性肺疾病及哮喘重叠综合征患者临床特征及其区别剖析   [摘要] 目的 探讨慢性阻塞性肺疾病(Chronic obstructive pulmonary disease,COPD)以及哮喘重叠综合征(asthma COPD overlap syndrome,ACOS)患者临床特征及其区别。 方法 前瞻性选取2016年2月~2017年2月我院收治的COPD患者60例以及ACOS患者60例,统计对比两组患者临床特征、肺功能及实验室指标方面的区别。 结果 两组患者的性别无明显差异(P0.05),ACOS患者的年龄、BMI指数以及外周血嗜酸性粒细胞百分比高于COPD患者(P0.05);ACOS患者的FEV1、FCV以及FEV1/FCV低于COPD患者,同时Dlco-SB、FeNO高于COPD患者(P0.05);实验室检查结果对比方面,ACOS患者PaO2低于对照组,同时WBC、CRP等指标高于对照组(P0.05)。 结论 ACOS患者的典型特征为气流受限,同COPD患者较为类似,因此需要分辨二者临床特征以及实验室指标等方面的区别,从而准确鉴别并为患者提供针对性治疗。   [关键词] 慢性阻塞性肺疾病;哮喘重叠综合征;临床特征;肺功能;实验室指标   [中图分类号] R563.9;R562.25 [文献标识码] B [文章编号] 1673-9701(2018)06-0031-04   [Abstract] Objective To investigate the clinical features and differences of patients with chronic obstructive pulmonary disease(COPD) and asthma COPD overlap syndrome (ACOS). Methods 60 patients with COPD and 60 patients with ACOS who were treated in our hospital from February 2016 to February 2017 were prospectively selected. The clinical characteristics, pulmonary function and laboratory indicators of the two groups were compared statistically. Results There was no significant gender difference between the two groups(P0.05). The age, BMI and the percentage of peripheral blood eosinophils in ACOS patients were higher than COPD patients(P0.05). The FEV1, FCV and FEV1/FCV in ACOS patients were lower than those in COPD patients, while Dlco-SB and FeNO were higher than COPD (P0.05). In terms of laboratory examination results, PaO2 in ACOS patients was lower than that in control group and WBC and CRP were significantly higher than control group (P0.05). Conclusion The typical characteristics of patients with ACOS are limited airflow and are similar to patients with COPD. Therefore, it is necessary to distinguish the difference between the clinical features and laboratory indicators of the two types of patients, so as to identify accurately and provide targeted treatment to patients.   [Key words] Chronic obstructive pulmonary disease, COPD; Asthma COPD overlap syndrome, ACOS

文档评论(0)

317960162 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档